XOMA Corporation Logo

XOMA Corporation

XOMAO

(1.2)
Stock Price

25,47 USD

-7.49% ROA

-19.34% ROE

-17.53x PER

Market Cap.

321.288.525,00 USD

121.22% DER

1.71% Yield

-119.61% NPM

XOMA Corporation Stock Analysis

XOMA Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

XOMA Corporation Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (0%), which means it has a small amount of debt compared to the ownership it holds

2 PBV

The stock's PBV ratio (1.66x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

3 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

4 Dividend

The company's track record of consistently paying dividends in the last three years highlights its dedication to providing investors with regular income.

5 ROE

Negative ROE (-27.62%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

6 ROA

The stock's ROA (-29.81%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

7 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

9 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

10 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

11 Buffet Intrinsic Value

The company's stock appears overvalued (1) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

XOMA Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

XOMA Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

XOMA Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

XOMA Corporation Revenue
Year Revenue Growth
1985 7.300.000
1986 100.000 -7200%
1987 7.700.000 98.7%
1988 5.000.000 -54%
1989 10.400.000 51.92%
1990 20.500.000 49.27%
1991 17.100.000 -19.88%
1992 5.100.000 -235.29%
1993 600.000 -750%
1994 1.700.000 64.71%
1995 1.200.000 -41.67%
1996 3.600.000 66.67%
1997 18.400.000 80.43%
1998 6.300.000 -192.06%
1999 2.400.000 -162.5%
2000 6.659.000 63.96%
2001 17.279.000 61.46%
2002 29.949.000 42.31%
2003 24.412.000 -22.68%
2004 3.665.000 -566.08%
2005 18.669.000 80.37%
2006 29.498.000 36.71%
2007 84.252.000 64.99%
2008 67.987.000 -23.92%
2009 98.430.000 30.93%
2010 33.641.000 -192.59%
2011 58.196.000 42.19%
2012 33.782.000 -72.27%
2013 35.451.000 4.71%
2014 18.866.000 -87.91%
2015 55.447.000 65.97%
2016 5.564.000 -896.53%
2017 52.690.000 89.44%
2018 5.299.000 -894.34%
2019 18.370.000 71.15%
2020 29.385.000 37.49%
2021 38.160.000 23%
2022 6.027.000 -533.15%
2023 3.320.000 -81.54%
2023 4.758.000 30.22%
2024 44.344.000 89.27%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

XOMA Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 27.300.000 100%
1995 22.100.000 -23.53%
1996 26.400.000 16.29%
1997 29.900.000 11.71%
1998 43.800.000 31.74%
1999 41.500.000 -5.54%
2000 30.006.000 -38.31%
2001 35.929.000 16.49%
2002 42.621.000 15.7%
2003 57.461.000 25.83%
2004 49.784.000 -15.42%
2005 39.896.000 -24.78%
2006 52.094.000 23.42%
2007 66.215.000 21.33%
2008 82.576.000 19.81%
2009 58.131.000 -42.05%
2010 77.413.000 24.91%
2011 68.137.000 -13.61%
2012 68.324.000 0.27%
2013 74.851.000 8.72%
2014 80.748.000 7.3%
2015 70.852.000 -13.97%
2016 44.234.000 -60.18%
2017 7.875.000 -461.7%
2018 1.682.000 -368.19%
2019 1.253.000 -34.24%
2020 170.000 -637.06%
2021 171.000 0.58%
2022 153.000 -11.76%
2023 100.000 -53%
2023 143.000 30.07%
2024 4.644.000 96.92%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

XOMA Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 5.500.000 100%
1997 5.600.000 1.79%
1998 5.400.000 -3.7%
1999 6.100.000 11.48%
2000 6.069.000 -0.51%
2001 8.681.000 30.09%
2002 19.405.000 55.26%
2003 24.489.000 20.76%
2004 31.977.000 23.42%
2005 14.798.000 -116.09%
2006 18.088.000 18.19%
2007 20.581.000 12.11%
2008 24.145.000 14.76%
2009 23.736.000 -1.72%
2010 23.250.000 -2.09%
2011 24.014.000 3.18%
2012 16.865.000 -42.39%
2013 18.477.000 8.72%
2014 19.866.000 6.99%
2015 20.620.000 3.66%
2016 18.322.000 -12.54%
2017 24.337.000 24.72%
2018 18.563.000 -31.1%
2019 21.002.000 11.61%
2020 16.799.000 -25.02%
2021 20.460.000 17.89%
2022 23.191.000 11.78%
2023 25.472.000 8.95%
2023 25.606.000 0.52%
2024 44.016.000 41.83%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

XOMA Corporation EBITDA
Year EBITDA Growth
1985 -5.000.000
1986 -47.200.000 89.41%
1987 -4.400.000 -972.73%
1988 -17.200.000 74.42%
1989 -30.200.000 43.05%
1990 -29.800.000 -1.34%
1991 -48.100.000 38.05%
1992 -28.000.000 -71.79%
1993 -35.500.000 21.13%
1994 -30.700.000 -15.64%
1995 -27.200.000 -12.87%
1996 -25.300.000 -7.51%
1997 -16.500.000 -53.33%
1998 -34.800.000 52.59%
1999 -45.200.000 23.01%
2000 -33.969.000 -33.06%
2001 -28.036.000 -21.16%
2002 -30.830.000 9.06%
2003 -54.307.000 43.23%
2004 -73.926.000 26.54%
2005 -71.430.000 -3.49%
2006 -34.614.000 -106.36%
2007 4.253.000 913.87%
2008 -30.516.000 113.94%
2009 23.443.000 230.17%
2010 -61.285.000 138.25%
2011 -28.598.000 -114.3%
2012 -48.425.000 40.94%
2013 -58.074.000 16.62%
2014 -79.946.000 27.36%
2015 -34.460.000 -132%
2016 -55.482.000 37.89%
2017 21.593.000 356.94%
2018 -10.608.000 303.55%
2019 -63.000 -16738.1%
2020 13.641.000 100.46%
2021 16.650.000 18.07%
2022 -17.015.000 197.85%
2023 -23.364.000 27.17%
2023 -20.988.000 -11.32%
2024 -4.304.000 -387.64%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

XOMA Corporation Gross Profit
Year Gross Profit Growth
1985 -1.200.000
1986 -41.300.000 97.09%
1987 9.100.000 553.85%
1988 -9.500.000 195.79%
1989 -13.800.000 31.16%
1990 14.900.000 192.62%
1991 10.600.000 -40.57%
1992 5.900.000 -79.66%
1993 3.200.000 -84.38%
1994 5.000.000 36%
1995 4.100.000 -21.95%
1996 5.700.000 28.07%
1997 20.400.000 72.06%
1998 7.900.000 -158.23%
1999 3.600.000 -119.44%
2000 4.790.000 24.84%
2001 17.279.000 72.28%
2002 29.949.000 42.31%
2003 24.412.000 -22.68%
2004 -12.708.000 292.1%
2005 18.669.000 168.07%
2006 29.498.000 36.71%
2007 84.252.000 64.99%
2008 67.987.000 -23.92%
2009 98.430.000 30.93%
2010 33.641.000 -192.59%
2011 58.196.000 42.19%
2012 33.639.000 -73%
2013 8.089.000 -315.86%
2014 -10.601.000 176.3%
2015 34.747.000 130.51%
2016 4.164.000 -734.46%
2017 44.815.000 90.71%
2018 3.617.000 -1139.01%
2019 17.117.000 78.87%
2020 29.215.000 41.41%
2021 37.989.000 23.1%
2022 5.930.000 -540.62%
2023 2.424.000 -144.64%
2023 3.858.000 37.17%
2024 44.332.000 91.3%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

XOMA Corporation Net Profit
Year Net Profit Growth
1985 -4.800.000
1986 -46.700.000 89.72%
1987 -4.800.000 -872.92%
1988 -12.000.000 60%
1989 -18.900.000 36.51%
1990 -23.700.000 20.25%
1991 -34.300.000 30.9%
1992 -47.100.000 27.18%
1993 -31.300.000 -50.48%
1994 -34.600.000 9.54%
1995 -22.500.000 -53.78%
1996 -29.100.000 22.68%
1997 -15.800.000 -84.18%
1998 -47.200.000 66.53%
1999 -45.800.000 -3.06%
2000 -29.412.000 -55.72%
2001 -28.040.000 -4.89%
2002 -33.247.000 15.66%
2003 -58.653.000 43.32%
2004 -78.942.000 25.7%
2005 2.779.000 2940.66%
2006 -51.841.000 105.36%
2007 -12.326.000 -320.58%
2008 -45.245.000 72.76%
2009 550.000 8326.36%
2010 -68.756.000 100.8%
2011 -32.743.000 -109.99%
2012 -71.065.000 53.93%
2013 -124.058.000 42.72%
2014 -38.301.000 -223.9%
2015 -20.606.000 -85.87%
2016 -53.530.000 61.51%
2017 14.596.000 466.74%
2018 -13.343.000 209.39%
2019 -7.698.000 -73.33%
2020 13.298.000 157.89%
2021 15.798.000 15.82%
2022 -17.104.000 192.36%
2023 -22.036.000 22.38%
2023 -40.831.000 46.03%
2024 63.940.000 163.86%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

XOMA Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1985 -171
1986 -1.908 91.03%
1987 -165 -1055.76%
1988 -336 50.89%
1989 -429 21.68%
1990 -504 14.88%
1991 -531 5.08%
1992 -660 19.55%
1993 -438 -50.68%
1994 -474 7.59%
1995 -285 -66.32%
1996 -269 -6.34%
1997 -120 -125.21%
1998 -330 63.94%
1999 -261 -26.92%
2000 -136 -91.18%
2001 -123 -10.57%
2002 -142 12.77%
2003 -234 39.74%
2004 -279 16.13%
2005 9 3200%
2006 -162 105.56%
2007 -29 -478.57%
2008 -102 72.55%
2009 1 10300%
2010 -74 101.37%
2011 -21 -265%
2012 -22 9.09%
2013 -29 21.43%
2014 -7 -300%
2015 -4 -133.33%
2016 -9 62.5%
2017 1 0%
2018 -2 100%
2019 -1 0%
2020 1 100%
2021 1 0%
2022 -2 200%
2023 -2 0%
2023 -4 66.67%
2024 4 200%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

XOMA Corporation Free Cashflow
Year Free Cashflow Growth
1989 -20.400.000
1990 -24.200.000 15.7%
1991 -34.000.000 28.82%
1992 -41.000.000 17.07%
1993 -30.700.000 -33.55%
1994 -29.800.000 -3.02%
1995 -30.700.000 2.93%
1996 -23.500.000 -30.64%
1997 -13.600.000 -72.79%
1998 -38.600.000 64.77%
1999 -44.100.000 12.47%
2000 -23.980.000 -83.9%
2001 -29.803.000 19.54%
2002 -44.974.000 33.73%
2003 -50.215.000 10.44%
2004 -47.470.000 -5.78%
2005 -49.034.000 3.19%
2006 -41.776.000 -17.37%
2007 -4.926.000 -748.07%
2008 -41.035.000 88%
2009 7.165.000 672.71%
2010 -52.876.000 113.55%
2011 -32.366.000 -63.37%
2012 -43.274.000 25.21%
2013 -47.084.000 8.09%
2014 -78.607.000 40.1%
2015 -31.322.000 -150.96%
2016 -33.748.000 7.19%
2017 2.678.000 1360.19%
2018 -27.650.000 109.69%
2019 -19.585.000 -41.18%
2020 8.883.000 320.48%
2021 -3.822.000 332.42%
2022 -36.126.000 89.42%
2023 -2.099.000 -1621.11%
2023 -32.825.000 93.61%
2024 2.647.000 1340.08%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

XOMA Corporation Operating Cashflow
Year Operating Cashflow Growth
1989 -18.300.000
1990 -22.600.000 19.03%
1991 -27.600.000 18.12%
1992 -34.200.000 19.3%
1993 -28.900.000 -18.34%
1994 -28.500.000 -1.4%
1995 -28.900.000 1.38%
1996 -22.400.000 -29.02%
1997 -12.000.000 -86.67%
1998 -37.700.000 68.17%
1999 -43.100.000 12.53%
2000 -22.461.000 -91.89%
2001 -22.422.000 -0.17%
2002 -34.841.000 35.64%
2003 -47.537.000 26.71%
2004 -44.827.000 -6.05%
2005 -44.190.000 -1.44%
2006 -33.270.000 -32.82%
2007 4.543.000 832.34%
2008 -32.975.000 113.78%
2009 7.435.000 543.51%
2010 -52.537.000 114.15%
2011 -29.062.000 -80.78%
2012 -40.765.000 28.71%
2013 -45.915.000 11.22%
2014 -78.282.000 41.35%
2015 -30.892.000 -153.41%
2016 -33.689.000 8.3%
2017 2.686.000 1354.24%
2018 -12.644.000 121.24%
2019 -285.000 -4336.49%
2020 10.092.000 102.82%
2021 22.678.000 55.5%
2022 -12.879.000 276.09%
2023 -2.099.000 -513.58%
2023 -18.158.000 88.44%
2024 2.647.000 785.98%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

XOMA Corporation Capital Expenditure
Year Capital Expenditure Growth
1989 2.100.000
1990 1.600.000 -31.25%
1991 6.400.000 75%
1992 6.800.000 5.88%
1993 1.800.000 -277.78%
1994 1.300.000 -38.46%
1995 1.800.000 27.78%
1996 1.100.000 -63.64%
1997 1.600.000 31.25%
1998 900.000 -77.78%
1999 1.000.000 10%
2000 1.519.000 34.17%
2001 7.381.000 79.42%
2002 10.133.000 27.16%
2003 2.678.000 -278.38%
2004 2.643.000 -1.32%
2005 4.844.000 45.44%
2006 8.506.000 43.05%
2007 9.469.000 10.17%
2008 8.060.000 -17.48%
2009 270.000 -2885.19%
2010 339.000 20.35%
2011 3.304.000 89.74%
2012 2.509.000 -31.69%
2013 1.169.000 -114.63%
2014 325.000 -259.69%
2015 430.000 24.42%
2016 59.000 -628.81%
2017 8.000 -637.5%
2018 15.006.000 99.95%
2019 19.300.000 22.25%
2020 1.209.000 -1496.36%
2021 26.500.000 95.44%
2022 23.247.000 -13.99%
2023 0 0%
2023 14.667.000 100%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

XOMA Corporation Equity
Year Equity Growth
1985 13.100.000
1986 12.000.000 -9.17%
1987 38.500.000 68.83%
1988 29.800.000 -29.19%
1989 27.100.000 -9.96%
1990 26.400.000 -2.65%
1991 134.500.000 80.37%
1992 88.500.000 -51.98%
1993 78.400.000 -12.88%
1994 43.500.000 -80.23%
1995 26.800.000 -62.31%
1996 34.700.000 22.77%
1997 31.200.000 -11.22%
1998 200.000 -15500%
1999 -16.900.000 101.18%
2000 -8.590.000 -96.74%
2001 13.619.000 163.07%
2002 -11.365.000 219.83%
2003 48.214.000 123.57%
2004 -24.610.000 295.91%
2005 -20.671.000 -19.06%
2006 -38.173.000 45.85%
2007 318.000 12104.09%
2008 -31.401.000 101.01%
2009 17.526.000 279.17%
2010 23.591.000 25.71%
2011 15.011.000 -57.16%
2012 21.467.000 30.07%
2013 -3.987.000 638.42%
2014 3.099.000 228.65%
2015 -2.309.000 234.21%
2016 -47.210.000 95.11%
2017 5.786.000 915.94%
2018 18.785.000 69.2%
2019 43.988.000 57.3%
2020 86.424.000 49.1%
2021 141.876.000 39.08%
2022 124.014.000 -14.4%
2023 105.964.000 -17.03%
2023 88.721.000 -19.44%
2024 99.993.000 11.27%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

XOMA Corporation Assets
Year Assets Growth
1985 14.900.000
1986 47.400.000 68.57%
1987 66.500.000 28.72%
1988 55.000.000 -20.91%
1989 110.500.000 50.23%
1990 97.000.000 -13.92%
1991 154.300.000 37.14%
1992 109.300.000 -41.17%
1993 94.100.000 -16.15%
1994 62.400.000 -50.8%
1995 40.900.000 -52.57%
1996 57.700.000 29.12%
1997 64.800.000 10.96%
1998 37.300.000 -73.73%
1999 28.300.000 -31.8%
2000 45.212.000 37.41%
2001 86.107.000 47.49%
2002 71.782.000 -19.96%
2003 118.850.000 39.6%
2004 46.260.000 -156.92%
2005 72.577.000 36.26%
2006 91.478.000 20.66%
2007 84.815.000 -7.86%
2008 67.173.000 -26.26%
2009 52.824.000 -27.16%
2010 74.252.000 28.86%
2011 78.036.000 4.85%
2012 105.676.000 26.16%
2013 134.782.000 21.59%
2014 89.631.000 -50.37%
2015 74.880.000 -19.7%
2016 28.677.000 -161.12%
2017 44.935.000 36.18%
2018 63.785.000 29.55%
2019 95.724.000 33.37%
2020 125.285.000 23.6%
2021 166.562.000 24.78%
2022 140.382.000 -18.65%
2023 124.094.000 -13.13%
2023 234.301.000 47.04%
2024 243.280.000 3.69%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

XOMA Corporation Liabilities
Year Liabilities Growth
1985 1.800.000
1986 35.400.000 94.92%
1987 28.000.000 -26.43%
1988 25.200.000 -11.11%
1989 83.400.000 69.78%
1990 70.600.000 -18.13%
1991 19.800.000 -256.57%
1992 20.800.000 4.81%
1993 15.700.000 -32.48%
1994 18.900.000 16.93%
1995 14.100.000 -34.04%
1996 23.000.000 38.7%
1997 33.600.000 31.55%
1998 37.100.000 9.43%
1999 45.200.000 17.92%
2000 53.802.000 15.99%
2001 72.488.000 25.78%
2002 83.147.000 12.82%
2003 70.636.000 -17.71%
2004 70.870.000 0.33%
2005 93.248.000 24%
2006 129.651.000 28.08%
2007 84.497.000 -53.44%
2008 98.574.000 14.28%
2009 35.298.000 -179.26%
2010 50.661.000 30.33%
2011 63.025.000 19.62%
2012 84.209.000 25.16%
2013 138.769.000 39.32%
2014 86.532.000 -60.37%
2015 77.189.000 -12.1%
2016 75.887.000 -1.72%
2017 39.149.000 -93.84%
2018 45.000.000 13%
2019 51.736.000 13.02%
2020 38.861.000 -33.13%
2021 24.686.000 -57.42%
2022 16.368.000 -50.82%
2023 18.130.000 9.72%
2023 145.580.000 87.55%
2024 143.287.000 -1.6%

XOMA Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1.31
Net Income per Share
-1.57
Price to Earning Ratio
-17.53x
Price To Sales Ratio
21.08x
POCF Ratio
-35.88
PFCF Ratio
-13.62
Price to Book Ratio
3.2
EV to Sales
19.64
EV Over EBITDA
-15.45
EV to Operating CashFlow
-33.6
EV to FreeCashFlow
-12.69
Earnings Yield
-0.06
FreeCashFlow Yield
-0.07
Market Cap
0,32 Bil.
Enterprise Value
0,30 Bil.
Graham Number
17.39
Graham NetNet
1.07

Income Statement Metrics

Net Income per Share
-1.57
Income Quality
0.49
ROE
-0.19
Return On Assets
-0.07
Return On Capital Employed
-0.09
Net Income per EBT
1
EBT Per Ebit
0.93
Ebit per Revenue
-1.28
Effective Tax Rate
0.49

Margins

Sales, General, & Administrative to Revenue
2.17
Research & Developement to Revenue
0.08
Stock Based Compensation to Revenue
0.72
Gross Profit Margin
0.97
Operating Profit Margin
-1.28
Pretax Profit Margin
-1.2
Net Profit Margin
-1.2

Dividends

Dividend Yield
0.02
Dividend Yield %
1.71
Payout Ratio
-0.3
Dividend Per Share
0.47

Operating Metrics

Operating Cashflow per Share
-0.77
Free CashFlow per Share
-2.03
Capex to Operating CashFlow
-1.65
Capex to Revenue
0.96
Capex to Depreciation
32.34
Return on Invested Capital
-0.04
Return on Tangible Assets
-0.07
Days Sales Outstanding
354.08
Days Payables Outstanding
789.49
Days of Inventory on Hand
0
Receivables Turnover
1.03
Payables Turnover
0.46
Inventory Turnover
0
Capex per Share
1.26

Balance Sheet

Cash per Share
12,42
Book Value per Share
8,59
Tangible Book Value per Share
8.59
Shareholders Equity per Share
8.59
Interest Debt per Share
11.06
Debt to Equity
1.21
Debt to Assets
0.5
Net Debt to EBITDA
1.13
Current Ratio
8.71
Tangible Asset Value
0,10 Bil.
Net Current Asset Value
0,02 Bil.
Invested Capital
143974000
Working Capital
0,14 Bil.
Intangibles to Total Assets
0
Average Receivables
0,01 Bil.
Average Payables
0,00 Bil.
Average Inventory
0.5
Debt to Market Cap
0.38

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

XOMA Corporation Dividends
Year Dividends Growth
2021 1
2022 2 50%
2023 2 0%
2024 2 0%

XOMA Corporation Profile

About XOMA Corporation

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

CEO
Mr. Owen P. Hughes Jr.
Employee
13
Address
2200 Powell Street
EmeryVille, 94608

XOMA Corporation Executives & BODs

XOMA Corporation Executives & BODs
# Name Age
1 Mr. Owen P. Hughes Jr.
Chief Executive Officer & Director
70
2 Mr. Brad Sitko
Chief Investment Officer
70
3 Mr. Thomas M. Burns
Senior Vice President of Finance & Chief Financial Officer
70

XOMA Corporation Competitors